EMG
IBER.U

Ellington Management Group’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History

Ellington Management Group’s Portfolio IBER.U Stock Details IBER.U Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$101K Hold
10,000
– – 0.02% 169
2021
Q1 		$99K Buy
+10,000
New +$100K 0.01% 159

Other funds holding IBER.U

HP
Hartree Partners New York $467M AUM 66.71% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
OPU
Omni Partners US Irvine, California $1.95B AUM
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ellington Management Group's IBER.U Position: Q2 2021 in Review

Ellington Management Group held its Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant (IBER.U) position steady in Q2 2021 at 10,000 shares worth $101K. The position accounts for 0.02% of the portfolio, ranked #169.

Ellington Management Group first reported a position in IBER.U in Q1 2021 and has held it in 2 quarters since. 34 funds tracked by Wall St. Rank hold IBER.U as of Q2 2021.

  • Ellington Management Group held 10,000 shares of Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant worth $101K as of Q2 2021.
  • Ellington Management Group left its Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant share count unchanged in Q2 2021.
  • Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant made up 0.02% of Ellington Management Group's portfolio in Q2 2021, its #169 holding.
  • Ellington Management Group first reported a position in Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant in Q1 2021 and has held it in 2 quarters since.
  • 34 funds tracked by Wall St. Rank held Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant as of Q2 2021.

Based on Ellington Management Group's 13F filing for Q2 2021, filed 16 Aug 2021.